Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurosci.

Sec. Translational Neuroscience

Volume 19 - 2025 | doi: 10.3389/fnins.2025.1666809

This article is part of the Research TopicPanoramic View of Cognitive Impairment: Interdisciplinary Cognitive Research, Volume IIView all articles

Frontal–Subcortical Dysfunction in Toxic Oil Syndrome: A Proof-of-Concept Eye-Tracking and Cognitive Study Four Decades After Exposure

Provisionally accepted
Julián  Benito LeónJulián Benito León1*José  LapelaJosé Lapela1Mariano  Ruiz-OrtizMariano Ruiz-Ortiz1Glen  Michael DonigerGlen Michael Doniger2Sonia  Álvarez-SesmeroSonia Álvarez-Sesmero1Verónica  Giménez de BejarVerónica Giménez de Bejar1María Antonia  NogalesMaría Antonia Nogales1Montserrat  MoralesMontserrat Morales1Ritwick  MondalRitwick Mondal3SHRAMANA  DEBSHRAMANA DEB3Fernando  BartolomeFernando Bartolome1Carolina  AlquezarCarolina Alquezar1Cecilia  García-CenaCecilia García-Cena4
  • 1Hospital Universitario 12 de Octubre, Madrid, Spain
  • 2NeuroTrax Corporation, Medina, United States
  • 3Manipal Hospitals, Kolkata, India
  • 4Universidad Politecnica de Madrid, Madrid, Spain

The final, formatted version of the article will be published soon.

Toxic Oil Syndrome (TOS) emerged in Spain in 1981 following ingestion of rapeseed oil adulterated with aniline derivatives. More than four decades later, survivors continue to report cognitive complaints, yet objective evidence of long-term dysfunction remains limited. We investigated saccadic eye movements and cognitive function in TOS survivors using validated eye-tracking paradigms and a standardized neuropsychological battery. In this case-control study, 47 TOS survivors and 44 matched healthy controls completed visually guided, memory-guided, and antisaccade tasks, as well as cognitive testing. The groups did not differ significantly in age, sex, or education. TOS participants showed preserved performance on visually guided and memory-guided saccades, with no significant group differences in latency, gain, peak velocity, or spatial error (all p > 0.05). By contrast, they exhibited significantly fewer correct antisaccades (mean 3.6 vs. 5.0; p = 0.029), more reflexive saccades (mean 7.0 vs. 5.7; p = 0.033), and increased backward reflexive saccades (mean 6.3 vs. 5.1; p = 0.040). Cognitive testing revealed selective impairments in executive function, attention, and processing speed, with preserved memory. Structural equation modeling confirmed that antisaccade impairment remained significant after adjustment for potential confounders and demonstrated an independent contribution of attention to performance. These findings indicate persistent frontal–subcortical circuit dysfunction in TOS survivors, resembling profiles observed in other toxic-immune encephalopathies. Eye-tracking provides a noninvasive, objective biomarker of latent executive dysfunction and may be valuable for long-term monitoring of populations exposed to environmental factors.

Keywords: toxic oil syndrome, Frontal-subcortical dysfunction, Saccadic eye movements, cognitive impairment, Eye-tracker

Received: 15 Jul 2025; Accepted: 27 Aug 2025.

Copyright: © 2025 Benito León, Lapela, Ruiz-Ortiz, Doniger, Álvarez-Sesmero, Giménez de Bejar, Nogales, Morales, Mondal, DEB, Bartolome, Alquezar and García-Cena. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Julián Benito León, Hospital Universitario 12 de Octubre, Madrid, Spain

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.